These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8141784)

  • 1. Fibrinogenolysis by a neutrophil membrane protease generates an A alpha 1-21 fragment.
    Kelly SL; Adams SA; Robson SC; Kirsch RE; Shephard EG
    Biochem J; 1994 Mar; 298 Pt 3(Pt 3):689-95. PubMed ID: 8141784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cleavage of fibrinogen by the human neutrophil neutral peptide-generating protease.
    Wintroub BU; Coblyn JS; Kaempfer CE; Austen KF
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5448-52. PubMed ID: 7001479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation products of fibrinogen by elastase-like neutral protease from human granulocytes. Characterization and effects on blood coagulation in vitro.
    Gramse M; Bingenheimer C; Schmidt W; Egbring R; Havemann K
    J Clin Invest; 1978 Apr; 61(4):1027-33. PubMed ID: 77863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human fibrinogen heterogeneity: the COOH-terminal residues of defective A alpha chains of fibrinogen II.
    Nakashima A; Sasaki S; Miyazaki K; Miyata T; Iwanaga S
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):361-70. PubMed ID: 1420813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing the beta-chain hole of fibrinogen with synthetic peptides that differ at their amino termini.
    Doolittle RF; Pandi L
    Biochemistry; 2007 Sep; 46(35):10033-8. PubMed ID: 17688324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural difference between polymerized and non-polymerized fragment X, obtained by plasmin digest of fibrinogen.
    Sato H; Swadesh JK
    Int J Biol Macromol; 1993 Dec; 15(6):323-7. PubMed ID: 8110652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of fibrinogen cleaved by Jararhagin, a metalloproteinase from the venom of Bothrops jararaca.
    Kamiguti AS; Slupsky JR; Zuzel M; Hay CR
    Thromb Haemost; 1994 Aug; 72(2):244-9. PubMed ID: 7831660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fibrinogenolytic activity of purified tryptase from human lung mast cells.
    Schwartz LB; Bradford TR; Littman BH; Wintroub BU
    J Immunol; 1985 Oct; 135(4):2762-7. PubMed ID: 3161948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen degradation by hementin, a fibrinogenolytic anticoagulant from the salivary glands of the leech Haementeria ghilianii.
    Malinconico SM; Katz JB; Budzynski AZ
    J Lab Clin Med; 1984 Nov; 104(5):842-54. PubMed ID: 6387015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of a 34-kDa, heat stable glycoprotein from Synadenium grantii latex: action on human fibrinogen and fibrin clot.
    Rajesh R; Nataraju A; Gowda CD; Frey BM; Frey FJ; Vishwanath BS
    Biochimie; 2006 Oct; 88(10):1313-22. PubMed ID: 16997451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of forms of fragment E with differing thrombin-binding properties during digestion of fibrinogen by plasmin.
    Goodwin CA; Kakkar VV; Scully MF
    Biochem J; 1992 Feb; 281 ( Pt 3)(Pt 3):613-8. PubMed ID: 1531588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct evidence for systemic fibrinogenolysis in patients with acquired alpha 2-plasmin inhibitor deficiency.
    Okajima K; Kohno I; Soe G; Okabe H; Takatsuki K; Binder BR
    Am J Hematol; 1994 Jan; 45(1):16-24. PubMed ID: 8250008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An enzyme immunoassay for polymorphonuclear leucocyte-mediated fibrinogenolysis.
    Bos R; van Leuven CJ; Stolk J; Hiemstra PS; Ronday HK; Nieuwenhuizen W
    Eur J Clin Invest; 1997 Feb; 27(2):148-56. PubMed ID: 9061309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin binding to the A alpha-, B beta-, and gamma-chains of fibrinogen and to their remnants contained in fragment E.
    Kaczmarek E; McDonagh J
    J Biol Chem; 1988 Sep; 263(27):13896-900. PubMed ID: 3417681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond.
    Bini A; Itoh Y; Kudryk BJ; Nagase H
    Biochemistry; 1996 Oct; 35(40):13056-63. PubMed ID: 8855941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence of plasmin proteolysis at the NH2-terminus of the b beta-chain of human fibrinogen.
    Koehn JA; Hurlet-Jensen A; Nossel HL; Canfield RE
    Anal Biochem; 1983 Sep; 133(2):502-10. PubMed ID: 6227262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant function of a 24-Kd fragment isolated from human fibrinogen A alpha chains.
    Lau HK
    Blood; 1993 Jun; 81(12):3277-84. PubMed ID: 8507865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct evidence for systemic fibrinogenolysis in a patient with metastatic prostatic cancer.
    Okajima K; Kohno I; Tsuruta J; Okabe H; Takatsuki K; Binder BR
    Thromb Res; 1992 Jun; 66(6):717-27. PubMed ID: 1519230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of neutrophil-mediated degradation of human C-reactive protein and identification of the protease.
    Shephard EG; Kelly SL; Anderson R; Fridkin M
    Clin Exp Immunol; 1992 Mar; 87(3):509-13. PubMed ID: 1544236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.